Johnson & Johnson (JNJ) Stock Price, Quote & News

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 732 524 0400

Website: www.jnj.com

Address:

One Johnson & Johnson Plaza, New Brunswick, United States

StageAnalysis Aug. 18 at 4:18 PM

Pharmaceuticals industry group is one of the strongest parts of the market currently Largest stocks in the group by weighting: $LLY, $JNJ, $MRK, $PFE, BMY, NVO, AZN, ZTS, NVS, AXSM, GSK, JAZZ, TEVA, RPRX, VTRS, SNY, ELAN, LQDA, DFTX, CORT, RHHBY, ELVN, TARS, NKTR, TAK, AMLX, SUPN, TRVI, RDY, PRGO, AMRX, OGN, PBH, HRMY, HROW, ANIP, OCUL, BHC, SEPN, INVA, MAZE, XERS, RAPP, LBRX, PAHC, CHGCY, GTBIF, MKKGY, TLX, HCM

1 · Reply

StockBraker Aug. 18 at 4:02 PM

$JNJ Don’t change that channel. 📺 👀

0 · Reply

HydrogenH2 Aug. 18 at 3:50 PM

$JNJ $AMGN $LLY and talking about Cramer ... "Cramer i'm not going to say that on tv !! " https://youtu.be/8DJlogbrDcA?t=74

0 · Reply

HydrogenH2 Aug. 18 at 3:46 PM

$JNJ $AMGN $LLY First Cantor Fitzgerald is this guy's family !! and always do opposite of Cramer's calls... here why... lol https://www.youtube.com/shorts/JTSl9Q38Ih0

0 · Reply

HydrogenH2 Aug. 18 at 3:43 PM

$JNJ

0 · Reply

HydrogenH2 Aug. 18 at 3:15 PM

$JNJ $ABBV I'm taking profits !! Thanks !!

0 · Reply

GettnFibbywIT Aug. 18 at 3:14 PM

$JNJ $XLV

0 · Reply

LiveTradePro Aug. 18 at 2:35 PM

$JNJ Patience paying off https://share.trendspider.com/chart/JNJ/6682yrl8al

0 · Reply

GordoHLYK13 Aug. 18 at 2:11 PM

$IGC $MRNA $PFE $ABB $JNJ

0 · Reply

parcha Aug. 18 at 1:31 PM

Jim Cramer's top 10 things to watch in the stock market Tuesday $AMGN $LLY $JNJ Cantor Fitzgerald and Mizuho both raised their price targets on Amgen, while keeping hold ratings on the stock. Cantor said the big question is whether Amgen’s late-stage pipeline can deliver the positive updates needed to keep the stock’s momentum going. We own Eli Lilly and Johnson & Johnson for the Club, with both seeing some encouraging prescription trends for new drugs in the first week of August. https://www.cnbc.com/2026/08/18/jim-cramers-top-10-things-to-watch-in-the-stock-market-tuesday.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension

0 · Reply

Expert explains why healthcare is a top-performing sector

ABBV AMGN BIIB GILD JNJ LLY MRK

Aug 10, 2026, 4:27 PM EDT - 7 days ago

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

JNJ

Aug 6, 2026, 6:23 PM EDT - 11 days ago

Jim Cramer highlights 5 investing themes — and the stocks to buy for each

AMAT AXP COF CRWD GS JNJ KLAC

Aug 4, 2026, 4:05 PM EDT - 13 days ago

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

JNJ

Aug 4, 2026, 8:45 AM EDT - 14 days ago

Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September

JNJ

Aug 3, 2026, 8:00 AM EDT - 15 days ago

Johnson & Johnson Transcript: Investor update

Aug 2, 2026, 8:00 AM EDT - 16 days ago

Inside J&J's Lab to Create a Simpler Robotic Surgery Device

JNJ

Jul 30, 2026, 8:30 AM EDT - 19 days ago

Johnson & Johnson's RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer

JNJ

Jul 29, 2026, 6:13 PM EDT - 19 days ago

Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines

JNJ

Jul 29, 2026, 5:42 PM EDT - 19 days ago

Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation

JNJ

Jul 29, 2026, 5:38 PM EDT - 19 days ago

Johnson & Johnson lowers 2026 profit forecast

JNJ

Jul 29, 2026, 5:28 PM EDT - 19 days ago

Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset

JNJ

Jul 29, 2026, 12:01 PM EDT - 20 days ago

Explainer: Can J&J finally put the talc litigation behind it?

JNJ

Jul 28, 2026, 4:31 PM EDT - 20 days ago

Johnson & Johnson offers $5.5 billion to settle remaining lawsuits over talc products linked to cancer

JNJ

Jul 28, 2026, 12:26 PM EDT - 21 days ago

Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits

JNJ

Jul 28, 2026, 1:03 AM EDT - 21 days ago

Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit

JNJ

Jul 28, 2026, 12:31 AM EDT - 21 days ago

J&J offers $5.5bn to settle baby powder lawsuits

JNJ

Jul 27, 2026, 9:29 PM EDT - 21 days ago

Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits

JNJ

Jul 27, 2026, 6:47 PM EDT - 21 days ago

Johnson & Johnson announces $5.5 billion settlement of talc lawsuits

JNJ

Jul 27, 2026, 6:31 PM EDT - 21 days ago

Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation

JNJ

Jul 27, 2026, 5:45 AM EDT - 22 days ago

Robert Kiyosaki sees a brutal depression ahead: 3 stocks that may protect portfolios

JNJ NEM WMT

$TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma$

Jul 23, 2026, 8:30 AM EDT - 26 days ago

TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma

JNJ

Jul 22, 2026, 4:33 PM EDT - 26 days ago

US judge casts doubt on 69,000 cases alleging J&J talc caused cancer

JNJ

Jul 22, 2026, 7:21 AM EDT - 27 days ago

Johnson & Johnson's robotic surgery device gets US FDA marketing authorization

JNJ

Jul 22, 2026, 7:00 AM EDT - 27 days ago

Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System

JNJ

Jul 21, 2026, 6:30 PM EDT - 27 days ago

Jim Cramer says this old-school investing concept still wins — even in the AI boom

BNY CVS GS JNJ MMM WFC

Jul 16, 2026, 8:11 AM EDT - 4 weeks ago

Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award

JNJ

Jul 16, 2026, 8:00 AM EDT - 4 weeks ago

DePuy Synthes Acquires Expanding Innovations™

JNJ

Jul 15, 2026, 12:09 PM EDT - 4 weeks ago

J&J Leverages AI and Robots to Target $100 Billion in Annual Revenue

JNJ

Jul 15, 2026, 8:30 AM EDT - 4 weeks ago

Johnson & Johnson Earnings Call Transcript: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 4 weeks ago

Johnson & Johnson Slides: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 4 weeks ago

Johnson & Johnson Earnings release: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 4 weeks ago

Johnson & Johnson Quarterly report: Q2 2026

Jul 15, 2026, 7:27 AM EDT - 4 weeks ago

ASML, Intel, Johnson & Johnson, and More Stocks That Explain Today's Market

ASML INTC JNJ

Jul 15, 2026, 6:35 AM EDT - 4 weeks ago

Johnson & Johnson Hikes Guidance, Stock Falls

JNJ

Jul 15, 2026, 6:33 AM EDT - 4 weeks ago

Johnson & Johnson Bumps Up Guidance as Sales Rise

JNJ

Jul 15, 2026, 6:25 AM EDT - 4 weeks ago

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026

JNJ

Jul 15, 2026, 6:23 AM EDT - 4 weeks ago

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit

JNJ

Jul 15, 2026, 6:20 AM EDT - 4 weeks ago

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

JNJ

Jul 9, 2026, 1:00 PM EDT - 5 weeks ago

The Big 3: UNH, KO, JNJ

JNJ KO UNH

Jul 8, 2026, 7:45 AM EDT - 5 weeks ago

Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform

JNJ

Jul 6, 2026, 6:29 PM EDT - 6 weeks ago

Jim Cramer says these are the 5 stocks to buy during this market rotation

JNJ PEP SBUX STZ TJX

Jun 26, 2026, 2:39 PM EDT - 7 weeks ago

Healthcare stocks have become a haven for investors ditching tech

ABBV ABSI APGE JNJ LLY MRNA SNY

Jun 26, 2026, 12:35 PM EDT - 7 weeks ago

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

JNJ

Jun 25, 2026, 5:00 AM EDT - 7 weeks ago

Johnson & Johnson Advances Cardiac Ablation Technology in Europe with Availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform

JNJ

Jun 15, 2026, 6:00 AM EDT - 2 months ago

Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida

JNJ

$New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma$

Jun 13, 2026, 6:41 AM EDT - 2 months ago

New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

JNJ

$New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma$

Jun 13, 2026, 6:33 AM EDT - 2 months ago

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma

JNJ

Jun 11, 2026, 7:45 AM EDT - 2 months ago

Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients

JNJ

Jun 11, 2026, 2:03 AM EDT - 2 months ago

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies

JNJ

Jun 10, 2026, 11:22 AM EDT - 2 months ago

Johnson & Johnson Hit with $32 Million Verdict in Los Angeles Asbestos Trial

JNJ

Jun 10, 2026, 6:20 AM EDT - 2 months ago

Johnson & Johnson CEO Says Cure for Certain Cancers Is Realistic Goal

JNJ

Jun 9, 2026, 10:00 AM EDT - 2 months ago

Johnson & Johnson Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO PFE

Jun 8, 2026, 9:01 AM EDT - 2 months ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion

JNJ

StageAnalysis Aug. 18 at 4:18 PM

1 · Reply

StockBraker Aug. 18 at 4:02 PM

$JNJ Don’t change that channel. 📺 👀

0 · Reply

HydrogenH2 Aug. 18 at 3:50 PM

$JNJ $AMGN $LLY and talking about Cramer ... "Cramer i'm not going to say that on tv !! " https://youtu.be/8DJlogbrDcA?t=74

0 · Reply

HydrogenH2 Aug. 18 at 3:46 PM

$JNJ $AMGN $LLY First Cantor Fitzgerald is this guy's family !! and always do opposite of Cramer's calls... here why... lol https://www.youtube.com/shorts/JTSl9Q38Ih0

0 · Reply

HydrogenH2 Aug. 18 at 3:43 PM

$JNJ

0 · Reply

HydrogenH2 Aug. 18 at 3:15 PM

$JNJ $ABBV I'm taking profits !! Thanks !!

0 · Reply

GettnFibbywIT Aug. 18 at 3:14 PM

$JNJ $XLV

0 · Reply

LiveTradePro Aug. 18 at 2:35 PM

$JNJ Patience paying off https://share.trendspider.com/chart/JNJ/6682yrl8al

0 · Reply

GordoHLYK13 Aug. 18 at 2:11 PM

$IGC $MRNA $PFE $ABB $JNJ

0 · Reply

parcha Aug. 18 at 1:31 PM

0 · Reply

Parlandoconme Aug. 18 at 10:17 AM

$TOMZ Buy now (Low) and sell later (High). This advice is only for Ray the day trader who has the opposite philosophy. $STE $AZN $JNJ $PEP

0 · Reply

ElliottwaveForecast Aug. 18 at 1:14 AM

$JNJ should continue rally targeting 271.37 or higher within daily bull run against May-2026 low. Short term pullback against 6.22.2026 low should remain supported to continue rally to extend ((5)). Check out the details at https://elliottwave-forecast.com/stock-market/jnj-elliott-wave-bullish-rally-targets-271-37-beyond/ #Elliottwave #JNJ

0 · Reply

DidYouReadThis Aug. 17 at 10:13 PM

$JNJ

0 · Reply

DidYouReadThis Aug. 17 at 10:07 PM

Who do you think is most likely to make an #acquisition first between now and the #end of the #year? Any #target predictions? $ABBV $JNJ $LLY $MRK #tenderoffer #Q3? #Q4?

0 · Reply

JimmyOcarri Aug. 17 at 8:37 PM

$LAZR $MXL $JNJ $JEPI $RMBS Q

0 · Reply

77HighStreet Aug. 17 at 8:09 PM

$JNJ Sold my JNJ today...I know, I am selling too early. But I have been in it for over 4 years and am more than grateful for my profit...besides, junior is entering his senior year at Auburn and I want to make sure I can pay the final tuition. Besides, if I sell, that is probably good luck for you guys. GLTA!

0 · Reply

SellasgpsCurativeBAT11 Aug. 17 at 4:03 PM

$JNJ $SLS Why Sellas will be one of the biggest BO of this decade? Sellas GPS Ad Infinitum Dosage + SLS009 Dual Platform offers end to end solutions to eradicate most dangerous cancers on the planet from start to finish= $200.00++ ✌️🙏❤️‍🩹

0 · Reply

BioBroke Aug. 17 at 4:01 PM

$SLS Let $JNJ announce the 80th event whenever that may happen.😉

0 · Reply

SellasgpsCurativeBAT11 Aug. 17 at 3:55 PM

$SLS $JNJ Johnson & Johnson announced on August 4, 2026, that Executive Vice President and Worldwide Chairman of Innovative Medicine Jennifer Taubert will retire, effective September 1, 2026. Tom Cavanaugh, currently Company Group Chairman for North America in the division, will succeed her. Mr. Cavanaugh and Sellas BOD Katherine Bach principals involved in biggest Pharmaceutical deal of all time. Bristol-Myers Squibb completed its $74 billion acquisition of Celgene Corporation on November 20, 2019. The cash-and-stock deal created a premier global biopharmaceutical giant focused on oncology, immunology, and cardiovascular disease. ✌️🙏❤️‍🩹

1 · Reply

Imr77 Aug. 17 at 3:50 PM

$SLS $JNJ same guy, shouting out to SLS and MSK (where they developed GPS first!)

0 · Reply

SellasgpsCurativeBAT11 Aug. 17 at 3:46 PM

$SLS $JNJ Part 3. Very interesting that $JNJ Michael Frascello, MBA • 3rd+ Product Director @ Johnson & Johnson | MBA, Marketing. Is always very first ones to like Dr. Stergiou posts every time. Probably a coincidence. 😆 ✌️🙏❤️‍🩹

0 · Reply

JuggernautRaider Aug. 17 at 10:56 AM

$PHAR needs a lot of help. Big Wim at Pharvarid $PHVS is about to eat their HAE lunch like Kalvista did before they got bounced. Pharming Group of NJ? It is a mess! I may help them. I may not. I have a couple of friends there… maybe if they ask niiiicely 😜 Maybe $AXSM should buy something like Tonix after all. NJ is a MESS! GO $JNJ GO! FIX AMERICAAAAAAAN HEALTHCARE 🇺🇸 🧪 🤖

0 · Reply

Market Cap	627.42B
Revenue (ttm)	94.19B
Net Income (ttm)	26.80B
EPS (ttm)	N/A
PE Ratio	24.13
Forward PE	22.57
Profit Margin	28.46%
Debt to Equity Ratio	0.44

Volume	3,339,453
Avg Vol	8,163,460
Day's Range	N/A - N/A
Shares Out	2.41B
Stochastic %K	81%
Beta	0.24
Analysts	Strong Sell
Price Target	$275.42